Rufinamide — CAS 106308-44-5

Rufinamide is a high-purity Active Pharmaceutical Ingredient (API) classified under Anticonvulsant / Antiepileptic Agent. Mediocon Inc manufactures GMP-compliant Rufinamide at its state-of-the-art facility in Aurangabad, Maharashtra, India, supplying pharmaceutical companies worldwide with consistent quality and full regulatory documentation.

• Lennox-Gastaut syndrome (LGS) seizures
• Adjunctive treatment of tonic and atonic seizures
• Refractory epilepsy management
• Sodium channel modulation

• GMP Certified manufacturing facility in Aurangabad, Maharashtra, India
• Full pharmacopoeial compliance: IP / BP / EP / USP standards
• Complete documentation: Certificate of Analysis (CoA), MSDS, Certificate of Origin
• Stringent in-process quality control at every manufacturing stage
• HPLC purity testing and spectroscopic identification (IR, NMR)
• Cold-chain and controlled-environment storage facilities available
• Exported to 40+ countries with full regulatory support